Health Canada is advising consumers and healthcare professionals about the rare, but potentially serious risk to infants when women take codeine-containing products while breastfeeding.
Celgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy.
